Evidence map›Paper›PMID 39744667›Full record

ArticleInfectious diseases & clinical microbiology2024

Isolation and Antibiotic Resistance Rates of

Dilara Yıldırım, Özlem Aldemir, Tuğba Yanık-Yalçın, Mesut Parlak

Abstract read
In one paragraph

Article in Infectious diseases & clinical microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dilara YıldırımDepartment of Medical Microbiology, Sivas Numune Hospital, Sivas, Türkiye.ORCID https://orcid.org/0000-0003-1317-1792
Özlem AldemirDepartment of Infectious Diseases and Clinical Microbiology, Sivas Numune Hospital, Sivas, Türkiye.ORCID https://orcid.org/0000-0002-9356-7510
Tuğba Yanık-YalçınDepartment of Infectious Diseases and Clinical Microbiology, Başkent University Ankara Hospital, Ankara, Türkiye.ORCID https://orcid.org/0000-0001-5996-8639
Mesut ParlakDepartment of Medical Pharmacology, Sivas Cumhuriyet University Faculty of Medicine, Sivas, Türkiye.ORCID https://orcid.org/0000-0001-9692-8396

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Tuberculosis (TB) is a public health problem. This study aimed to determine the growth rates and drug susceptibility levels of patients with Materials and Methods: The study included patients who were Erlich Ziehl Neelsen (EZN) positive or negative and whose samples showed MTC growth in culture and susceptibility to the main drugs used in the treatment of TB, including streptomycin (SM), isoniazid (INH), rifampicin (RIF) and ethambutol (EMB). Patient samples were inoculated simultaneously into liquid TK Results: The study found resistance to dual drugs at 5.4%, INH+RIF at 1.35%, INH at 6.8%, RIF at 14.8%, EMB at 17.6%, and SM at 1.35%. Out of 69 samples cultured in LJ medium, three failed to grow in liquid TK Conclusion: We found that the drug resistance rates we obtained in our study were similar to the results of the Republic of Türkiye Ministry of Health and other studies conducted in our country. In a joint study conducted with liquid and solid media, no difference was found in the detection of TB bacilli. Mycolor TK

Indexed as

drug resistanceidentificationMycobacterium tuberculosisMycolor TK®

Identifiers

PMID39744667
PMCPMC11687229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.